Top of page

IP & Commercial Transactions

Practice

Filters

Generation Bio $230 million IPO

Davis Polk advised the representatives of the underwriters in connection with the $230 million initial public offering…

Legend Biotech $487 million IPO

Davis Polk advised the underwriters in connection with the $487 million SEC-registered initial public offering by Legend…

ADC Therapeutics $267 million IPO

Davis Polk advised ADC Therapeutics SA on its SEC-registered initial public offering of 14,082,475 common shares, which…
Back to top